Building a Transparent and Cost-Effective Drug Spend Strategy

Description

99% of employers believe drug prices are a significant threat to health benefits affordability, according to a 2024 survey of employer members of coalitions that belong to the National Alliance of Healthcare Purchasing Coalitions. And 55% of those believe PBM conflicts of interest represent a significant threat. Moreover, 52% of respondents plan to change PBMs in the next 1-3 years. The fastest-growing PBM strategies include confirming transparent revenue disclosure, comprehensive rebate definition, and flexibility to customize formularies.

The Winter Forum brings together employers/purchasers of all sizes and industries to learn from experts and network with healthcare and benefits leaders. The Forum will include a mix of panel discussions, employer case studies, and workshops. To kickstart the forum, attendees will have an opportunity to watch a screening of the soon-to-be-released documentary, Side Effects May Include: The Hidden Costs of Prescription Drugs.